Perioral pallor and Dennie's line are seen in which of the following conditions?
In thromboasthenia, what defect is present?
A 12-year-old girl who underwent a bone marrow transplant as part of therapy for ALL presents with pulmonary complaints and neurologic findings. Lung biopsy reveals a granulomatous vasculitis with associated atypical lymphocytes. Clonality studies reveal a monoclonal B cell population with associated polyclonal T cells. What infectious agent is related to this diagnosis?
The t(15;19) translocation is associated with which of the following conditions?
Cabot's rings are features of which condition?
The RBC morphology in a peripheral blood smear in thalassemia trait resembles that of which condition?
The Philadelphia chromosome is characteristically seen in which of the following conditions?
Cyclin D1/IgH gene rearrangement is associated with which of the following malignancies?
Sideroblasts are seen in all conditions except?
Neoplastic giant cells characteristically seen in Hodgkin's lymphoma are:
Explanation: **Explanation:** **Atopic Dermatitis (AD)** is a chronic, relapsing inflammatory skin condition characterized by a defective skin barrier (often due to **Filaggrin mutations**) and Type I hypersensitivity [1]. The diagnosis is primarily clinical, based on the **Hanifin and Rajka criteria**. * **Why Option A is correct:** Perioral pallor and Dennie-Morgan lines are classic "minor criteria" for Atopic Dermatitis. * **Dennie-Morgan Line:** An infraorbital fold or wrinkle caused by chronic edema and inflammation of the lower eyelid. * **Perioral Pallor:** A characteristic paleness around the mouth, often contrasting with the erythematous, eczematous patches on the cheeks (especially in infants). * **Why other options are incorrect:** * **Chronic Actinic Dermatitis:** A photosensitive disorder occurring on sun-exposed areas; it does not typically present with infraorbital folds. * **Blood Dyscrasia:** While anemia (a dyscrasia) causes general pallor [1], it does not specifically cause localized perioral pallor or Dennie-Morgan lines. * **Perioral Contact Dermatitis:** This usually presents with erythema, scaling, and papules *around* the mouth, rather than a distinct zone of pallor. **High-Yield Clinical Pearls for NEET-PG:** * **Filaggrin (FLG) Gene:** The most common genetic association with AD. * **Atopic March:** The progression from Atopic Dermatitis → Food Allergy → Allergic Rhinitis → Asthma. * **Hertoghe’s Sign:** Thinning or loss of the lateral third of the eyebrows due to chronic rubbing (common in AD). * **Pityriasis Alba:** Hypopigmented, slightly scaly patches on the face; another minor criterion for AD. * **Serum IgE:** Typically elevated in the extrinsic type of Atopic Dermatitis. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 634-636.
Explanation: **Explanation:** **Glanzmann Thromboasthenia (GT)** is an autosomal recessive bleeding disorder characterized by a qualitative defect in platelets [1]. 1. **Why Option A is Correct:** The underlying defect in GT is a deficiency or dysfunction of the **Glycoprotein IIb/IIIa (GPIIb/IIIa)** complex [1], [2]. This receptor is essential for **platelet aggregation** because it binds to fibrinogen, which acts as a bridge between two adjacent platelets [2]. Without functional GPIIb/IIIa, platelets cannot clump together, leading to a primary hemostatic defect despite a normal platelet count [1]. 2. **Why Other Options are Incorrect:** * **Option B (Adhesion):** Platelet adhesion to the subendothelial matrix is mediated by **GPIb-IX-V** binding to von Willebrand Factor (vWF) [1], [2]. A defect here results in **Bernard-Soulier Syndrome**, not thromboasthenia [1]. * **Options C & D (Release/Secretion):** These refer to "Storage Pool Diseases" (e.g., Gray Platelet Syndrome or Delta-storage pool deficiency), where the defect lies in the alpha or dense granules, not the surface aggregation receptors [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Platelet Morphology:** In GT, platelets are normal in size and count (unlike Bernard-Soulier, where they are large and decreased). * **Platelet Aggregometry:** This is the gold standard diagnostic test. In GT, there is **failure of aggregation with all agonists** (ADP, Collagen, Epinephrine, Thrombin) **EXCEPT Ristocetin** [1]. * **Ristocetin Test:** Ristocetin-induced agglutination is **normal** in GT because it depends on GPIb and vWF, which are intact. (In Bernard-Soulier and vWD, Ristocetin agglutination is abnormal) [1], [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, pp. 668-670. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Hemodynamic Disorders, Thromboembolic Disease, and Shock, p. 128.
Explanation: ### Explanation The clinical presentation describes **Post-Transplant Lymphoproliferative Disorder (PTLD)**, specifically a subtype resembling **Lymphomatoid Granulomatosis**. **1. Why EBV is the Correct Answer:** PTLD is a serious complication following hematopoietic stem cell or solid organ transplantation. It occurs due to the therapeutic suppression of T-cell immunity, which allows for the uncontrolled proliferation of B-cells infected with the **Epstein-Barr Virus (EBV)** [1]. * **Pathology:** The "granulomatous vasculitis" and "atypical lymphocytes" in the lung are classic features of Lymphomatoid Granulomatosis, an EBV-associated B-cell proliferation. * **Clonality:** The presence of a **monoclonal B-cell population** (driven by EBV) surrounded by reactive **polyclonal T-cells** is a hallmark of this condition [3]. EBV proteins (like LMP-1) mimic CD40 signaling, driving B-cell survival and expansion [2]. **2. Why Other Options are Incorrect:** * **CMV (Cytomegalovirus):** While common post-transplant, it typically causes interstitial pneumonitis with characteristic "owl’s eye" intranuclear inclusions, not monoclonal B-cell proliferation or granulomatous vasculitis [4]. * **HPV (Human Papillomavirus):** Associated with squamous cell carcinomas (cervix, oropharynx) and warts, not post-transplant lymphoproliferative disorders. * **HHV-8 (Human Herpesvirus 8):** Associated with Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease. While it causes malignancy in immunosuppressed patients, it does not typically present as granulomatous vasculitis in the lungs [1]. **3. NEET-PG High-Yield Pearls:** * **PTLD Spectrum:** Ranges from early polyclonal hyperplasia to monomorphic B-cell or T-cell lymphomas. * **Lymphomatoid Granulomatosis:** An "angiocentric and angiodestructive" EBV-positive B-cell lesion. It primarily affects the lungs, followed by the kidney, skin, and CNS. * **Treatment:** Often involves reduction of immunosuppression and Rituximab (anti-CD20). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 181-182. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 368-369. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 369-370. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 367-368.
Explanation: ### Explanation **Correct Answer: B. Chronic neutrophilic leukemia** **1. Why the correct answer is right:** Chronic Neutrophilic Leukemia (CNL) is a rare BCR-ABL1-negative myeloproliferative neoplasm (MPN). While the most common molecular driver in CNL is the **CSF3R T618I mutation** (present in >80% of cases), specific cytogenetic abnormalities are also associated with the disease. The **t(15;19)(q13;p13.3)** translocation is a characteristic, albeit rare, cytogenetic marker for CNL. This translocation involves the *BRD4* gene on chromosome 19 and the *NUT* gene on chromosome 15, though in the context of CNL, it is specifically recognized as a diagnostic clue when CSF3R mutations are absent. **2. Why the incorrect options are wrong:** * **A. Chronic Myelogenous Leukemia (CML):** CML is defined by the **t(9;22)** translocation [2], resulting in the *BCR-ABL1* fusion gene (Philadelphia chromosome) [1]. * **C. Chronic Eosinophilic Leukemia (CEL):** CEL is frequently associated with rearrangements involving **PDGFRα** (4q12), **PDGFRβ** (5q32), or **FGFR1** (8p11) [1]. The most common is the *FIP1L1-PDGFRA* fusion [1]. * **D. Essential Thrombocytosis (ET):** ET is characterized by mutations in **JAK2 V617F** (~55%), **CALR** (~25%), or **MPL** (~4%) [1]. It does not have a specific diagnostic translocation like t(15;19). **3. Clinical Pearls for NEET-PG:** * **CSF3R T618I:** This is the "hallmark" mutation for CNL and is a high-yield fact for recent exams. * **Diagnostic Criteria:** CNL requires a sustained peripheral blood white cell count ≥ 25 x 10⁹/L, with >80% neutrophils and <10% immature myeloid cells (blasts are rarely seen). * **Splenomegaly:** Almost all CNL patients present with significant splenomegaly [3]. * **Differentiate from Leukemoid Reaction:** Unlike a leukemoid reaction, CNL will show clonal markers (like CSF3R or t(15;19)) and a low/absent LAP (Leukocyte Alkaline Phosphatase) score is not reliable here; molecular testing is gold standard. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 624. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 225-226. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 625-626.
Explanation: **Explanation:** **Cabot’s rings** are thin, red-purple, thread-like strands found inside erythrocytes. They typically appear in the shape of a loop or a "figure-of-eight." Morphologically, they are remnants of the **mitotic spindle** (microtubules) or fragments of the nuclear membrane, indicating a defect in erythrocyte production. **Why Pernicious Anaemia is correct:** Cabot’s rings are most characteristically seen in conditions of **severe dyserythropoiesis** (abnormal RBC formation). Pernicious anaemia, a form of Megaloblastic anaemia caused by Vitamin B12 deficiency, leads to significant maturation defects in the bone marrow [1]. Other conditions where they may be seen include lead poisoning and homozygous thalassemia. **Why other options are incorrect:** * **Multiple Myeloma:** This is a plasma cell dyscrasia. The classic peripheral smear finding is **Rouleaux formation** (stacking of RBCs) due to high paraprotein levels, not nuclear remnants. * **Burkitt’s Lymphoma:** This is a high-grade B-cell lymphoma. The hallmark is the **"Starry sky appearance"** on lymph node biopsy and "hand-mirror" cells or vacuolated blasts on a blood film, rather than Cabot's rings. **High-Yield Clinical Pearls for NEET-PG:** * **Howell-Jolly Bodies:** DNA remnants (seen in post-splenectomy/hyposplenism). * **Basophilic Stippling:** Ribosomal RNA precipitates (seen in Lead poisoning and Thalassemia). * **Pappenheimer Bodies:** Siderotic (iron) granules (seen in Sideroblastic anaemia). * **Heinz Bodies:** Denatured hemoglobin (seen in G6PD deficiency; visualized with supra-vital stains like Crystal Violet). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 592-593.
Explanation: **Explanation:** The correct answer is **Iron Deficiency Anemia (IDA)**. Both Thalassemia trait and IDA are characterized by a **microcytic hypochromic** blood picture [1]. **1. Why Iron Deficiency Anemia is correct:** In both conditions, there is a defect in hemoglobin synthesis—IDA due to lack of iron and Thalassemia due to reduced globin chain production [1]. This results in small (microcytic) and pale (hypochromic) RBCs. Morphological similarities include the presence of **target cells** (codocytes), though they are typically more numerous in Thalassemia. **2. Why other options are incorrect:** * **Vitamin B12 and Folate Deficiency (Options A & B):** These are **megaloblastic anemias** characterized by **macrocytic** (large) RBCs and hypersegmented neutrophils [3]. This is the morphological opposite of the microcytic cells seen in Thalassemia. * **Hereditary Spherocytosis (Option C):** This condition presents with **spherocytes**—small, dark-staining RBCs that lack central pallor due to a membrane defect [2]. In contrast, Thalassemia cells have increased central pallor (hypochromia). **NEET-PG High-Yield Pearls:** * **Mentzer Index:** Used to differentiate IDA from Thalassemia trait. * **MCV/RBC count < 13** suggests Thalassemia trait (high RBC count relative to MCV). * **MCV/RBC count > 13** suggests Iron Deficiency Anemia. * **RDW (Red Cell Distribution Width):** Usually **normal** in Thalassemia trait (uniform cell size) but **elevated** in IDA (anisocytosis). * **Confirmatory Test:** Hb Electrophoresis is the gold standard for Thalassemia (showing raised HbA2 >3.5%), while Serum Ferritin is the best initial test for IDA. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 590-591. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 638. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 594-595.
Explanation: **Explanation:** The Philadelphia (Ph) chromosome is a hallmark cytogenetic abnormality resulting from a reciprocal translocation between chromosomes 9 and 22, denoted as **t(9;22)(q34;q11)** [1]. This translocation fuses the *ABL1* gene on chromosome 9 with the *BCR* gene on chromosome 22, creating the **BCR-ABL1 fusion gene** [2]. This gene encodes a chimeric protein with constitutive tyrosine kinase activity, driving uncontrolled cellular proliferation [2]. **Why Option C is Correct:** * **Chronic Myeloid Leukemia (CML):** The Ph chromosome is the diagnostic hallmark of CML, present in **>95%** of cases [2]. It is typically associated with the **p210** protein isoform. * **Acute Lymphoblastic Leukemia (ALL):** The Ph chromosome is also found in approximately **25-30% of adult ALL** cases and **3-5% of pediatric ALL** cases. In ALL, it is often associated with the **p190** protein isoform and signifies a poor prognosis. **Why other options are incorrect:** * **Option A & B:** While the Ph chromosome is most famously associated with CML, selecting only one leukemia is incomplete. Because it serves as a major diagnostic and prognostic marker in both conditions, "Both" is the most accurate answer. **NEET-PG High-Yield Pearls:** 1. **Molecular Weight:** CML is usually associated with **p210** (Major breakpoint), while Ph+ ALL is more commonly associated with **p190** (Minor breakpoint). 2. **Prognosis:** In ALL, the presence of t(9;22) is a **poor prognostic indicator**. 3. **Targeted Therapy:** The discovery of the Ph chromosome led to the development of **Imatinib (Gleevec)**, a tyrosine kinase inhibitor (TKI) that revolutionized the treatment of these malignancies [3]. 4. **Detection:** Gold standard methods include Conventional Karyotyping, FISH (Fluorescence In Situ Hybridization), and RT-PCR [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 225-226. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 624. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 611-612.
Explanation: **Mantle Cell Lymphoma (MCL)** is characterized by the pathognomonic chromosomal translocation **t(11;14)(q13;q32)** [1]. This translocation involves the **CCND1 gene** (encoding Cyclin D1) on chromosome 11 and the **Immunoglobulin Heavy chain (IgH) locus** on chromosome 14 [2]. The juxtaposition leads to the overexpression of Cyclin D1, a protein that promotes the transition from the G1 to the S phase of the cell cycle by phosphorylating the Retinoblastoma (Rb) protein [2]. Immunohistochemistry (IHC) typically shows positivity for **Cyclin D1 and CD5**, while being negative for CD23 [2]. **Analysis of Incorrect Options:** * **Hairy Cell Leukemia:** Associated with the **BRAF V600E** mutation. It typically presents with massive splenomegaly and "dry tap" on bone marrow aspiration. * **Follicular Lymphoma:** Characterized by **t(14;18)**, involving the **BCL-2** gene [4,5]. This leads to the overexpression of BCL-2, an anti-apoptotic protein [4,5]. * **Diffuse Large B-cell Lymphoma (DLBCL):** A heterogeneous group; however, it is most commonly associated with rearrangements of **BCL-6** (30% of cases) or t(14;18) [3]. **High-Yield Pearls for NEET-PG:** * **MCL Marker:** CD5 positive, CD23 negative (helps differentiate from CLL/SLL which is CD5+ and CD23+). * **Morphology:** Presence of "centrocyte-like" cells [2]. * **Clinical:** Often presents at an advanced stage; may involve the GI tract as **lymphomatous polyposis** [1]. * **Translocation Mnemonic:** "Mantle" has 11 letters (if you count carefully or use it as a hook) → t(11;14). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 562-563. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 610-612. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 563-564. [4] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 561-562. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 602-604.
Explanation: **Explanation:** The presence of **sideroblasts** (nucleated erythroblasts with iron granules in the cytoplasm) is a hallmark of disorders where iron utilization is impaired despite adequate iron stores. **Why Thalassemia is the correct answer:** In **Thalassemia**, the primary defect is a quantitative deficiency in globin chain synthesis [1]. While iron overload can occur due to repeated transfusions or increased absorption, the iron is typically deposited in the reticuloendothelial system or as diffuse ferritin [3]. Thalassemia is characterized by **target cells** and microcytic hypochromic anemia, but it is not classically associated with the formation of ring sideroblasts in the bone marrow, which require a defect in the heme synthesis pathway itself [2]. **Analysis of other options:** * **Alcoholism:** Alcohol is a mitochondrial toxin that inhibits several enzymes in the heme synthesis pathway (like ferrochelatase), leading to the formation of ring sideroblasts. * **Iron Overload:** Conditions like primary or secondary hemochromatosis lead to excessive iron deposition within developing erythroblasts. * **Myelofibrosis:** Sideroblasts can be seen in various myeloproliferative and myelodysplastic syndromes (MDS). Specifically, Refractory Anemia with Ring Sideroblasts (RARS) is a subtype of MDS where sideroblasts are a defining feature. **NEET-PG High-Yield Pearls:** * **Ring Sideroblasts:** Defined as having $\geq$ 5 iron granules covering at least one-third of the nuclear circumference. * **Stain used:** **Prussian Blue (Perl’s stain)** is essential to visualize siderotic granules. * **Common Causes of Sideroblastic Anemia:** Remember the mnemonic **LEAD**: **L**ead poisoning, **E**thanol (Alcohol), **A**INH (Isoniazid), and **D**eficiency of Vitamin B6 (Pyridoxine). * **Key Enzyme:** The most common congenital cause is a defect in **ALAS-2** (delta-aminolevulinate synthase). **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 600-601. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 590-591. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Red Blood Cell and Bleeding Disorders, p. 648.
Explanation: **Explanation:** **Correct Answer: C. Reed-Sternberg (RS) cells** Reed-Sternberg cells are the hallmark neoplastic cells of Hodgkin’s Lymphoma (HL) [1]. They are derived from germinal center B-cells [1]. Morphologically, a classic RS cell is a large cell (15–45 µm) with abundant cytoplasm and at least two nuclear lobes or nuclei [2]. These nuclei possess large, acidophilic, "owl-eye" nucleoli surrounded by a clear halo [2]. Their presence in a characteristic reactive inflammatory background is essential for the diagnosis of HL [1]. **Analysis of Incorrect Options:** * **A. Warthin-Finkeldey cells:** These are multinucleated giant cells with "grape-like" nuclear clusters found in hyperplastic lymph nodes during the prodromal stage of **Measles**. * **B. Russell bodies:** These are eosinophilic, homogeneous cytoplasmic inclusions representing accumulated immunoglobulin within **Plasma cells**. They are seen in conditions like Multiple Myeloma or chronic inflammation. * **D. Mikulicz cells:** These are large, foamy macrophages containing *Klebsiella rhinoscleromatis*, characteristic of **Rhinoscleroma** (a chronic granulomatous condition of the nose). **High-Yield Clinical Pearls for NEET-PG:** * **Immunophenotype:** Classic RS cells are typically **CD15+ and CD30+**, but **CD20- and CD45-**. * **Variants:** * *L&H Cells (Popcorn cells):* Seen in Nodular Lymphocyte Predominant HL (CD20+, CD15-, CD30-) [4]. * *Lacunar cells:* Characteristic of the Nodular Sclerosis variant [2]. * **Bimodal Age Distribution:** HL shows peaks in the 20s and after age 50 [1]. * **EBV Association:** Most commonly associated with the Mixed Cellularity subtype [3]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 614-616. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 616. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 616-618. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 618.
Anemias: Classification and Approach
Practice Questions
Hemolytic Anemias
Practice Questions
Myeloproliferative Neoplasms
Practice Questions
Myelodysplastic Syndromes
Practice Questions
Acute Leukemias
Practice Questions
Chronic Leukemias
Practice Questions
Lymphomas and Lymphoid Neoplasms
Practice Questions
Plasma Cell Disorders
Practice Questions
Bleeding Disorders
Practice Questions
Thrombotic Disorders
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free